Detalles de la búsqueda
1.
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Cancer Immunol Immunother
; 72(11): 3707-3716, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638980
2.
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.
Explor Target Antitumor Ther
; 4(4): 743-756, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37720351
3.
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals.
Acta Biomed
; 92(3): e2021091, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212933
4.
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer.
Cancer Immunol Immunother
; 59(4): 553-61, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19779715
5.
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Immunotherapy
; 12(15): 1139-1148, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32933369
6.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Lung Cancer
; 150: 123-131, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130353
7.
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Eur J Cancer
; 130: 155-167, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32220780
8.
Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
Endocr Relat Cancer
; 15(4): 1013-24, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18632876
9.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Clin Cancer Res
; 13(21): 6518-26, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17975165
10.
Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review.
Curr Drug Targets
; 19(14): 1649-1656, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437006
11.
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Breast
; 16(3): 280-92, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17257844
12.
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.
Acta Biomed
; 78(3): 204-9, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18330080
13.
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Lung Cancer
; 104: 24-30, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212996
14.
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.
Lung Cancer
; 53(1): 103-9, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16716446
15.
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Acta Biomed
; 87(1): 54-63, 2016 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27163896
16.
Hepatic artery administration of docetaxel in liver metastases from breast carcinoma: a feasibility study.
Tumori
; 91(2): 121-5, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15948537
17.
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Tumori
; 91(6): 505-12, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16457150
18.
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
Lung Cancer
; 88(3): 319-24, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25870156
19.
Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Lung Cancer
; 41(1): 101-6, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12826318
20.
Design and development of new combinations of the CMF agents with taxanes (paclitaxel or docetaxel) in advanced breast cancer: a feasibility study.
Tumori
; 90(3): 280-4, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15315305